- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about SMMT
Recent news which mentions SMMT
3 No-Brainer Biotech Stocks to Buy With $200 Right Now
December 18, 2024
From Motley Fool
2 Soaring Stocks That Could Climb 68% to 166% Higher in 2025, According to Wall Street
December 15, 2024
From Motley Fool
Investing $5,000 in Each of These 3 Stocks at the Start of 2024 Would Have Created a Portfolio Worth More Than $100,000 Today
December 14, 2024
From Motley Fool
Why Summit Therapeutics Stock Rocketed 6% Higher on Friday
December 06, 2024
From Motley Fool
Billionaire Ken Griffin Is Selling Palantir and Buying a Stock Wall Street Expects to Rocket 139% Higher
December 02, 2024
From Motley Fool
3 Monster Stocks in the Making
November 23, 2024
From Motley Fool
BioNTech Earns Upgrade From Goldman Sachs As Investment Thesis Shifts Toward Cancer Potential
November 09, 2024
From Benzinga
2 Hot Biopharma Stocks to Buy and Hold for 5 Years
November 08, 2024
From Motley Fool
Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo
November 04, 2024
From Benzinga
This Tencent Music Entertainment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
November 04, 2024
From Benzinga
3 Magnificent Stocks Under $100 to Buy in November
November 03, 2024
From Motley Fool
2 Dividend Stocks to Buy for a Lifetime of Passive Income
November 02, 2024
From Motley Fool
3 Stocks That Have Generated 1,000% Returns in Just 2 Years
October 31, 2024
From Motley Fool
Up Over 600% in 2024, Can Summit Therapeutics Stock Keep Rising?
October 24, 2024
From Motley Fool
Billionaire Bob Duggan Snags $33M Miami Penthouse Amid Summit Therapeutics 689% Stock Rally
October 24, 2024
From Benzinga
Billionaire Israel Englander Just Quietly Took a Stake in This Potentially Lucrative Pharmaceutical Stock. Should You?
October 22, 2024
Tickers
SMMT
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
October 16, 2024
From Benzinga
Up 700% This Year, Is It Too Late to Invest in This Stock?
October 15, 2024
From Motley Fool
Better Biotech Stock to Buy With $1,500 Right Now: Viking Therapeutics vs. Summit Therapeutics
October 13, 2024
From Motley Fool
3 Things You Need to Know If You Buy Summit Therapeutics Stock Today
October 12, 2024
Tickers
SMMT
From Motley Fool
2 Soaring Stocks That Could Climb Another 112% and 120%, According to Wall Street Analysts
October 07, 2024
From Motley Fool
Coinbase, Nike And Moderna Are Among Top 11 Large Cap Losers Last Week (Sept 30-Oct 4): Are The Others In Your Portfolio?
October 06, 2024
From Benzinga
Could Summit Therapeutics Become the Next Merck?
October 04, 2024
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.